30555541|t|Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer.
30555541|a|Cisplatin resistance significantly affects the survival rate of patients with ovarian cancer. However, the main mechanism underlying cisplatin resistance in ovarian cancer remains unclear. Methods: Immunohistochemistry was used to determine the expression of OGT, OGA and O-GlcNAc in chemoresistant and chemosensitive ovarian cancer tissues. Functional analyses (in vitro and in vivo) were performed to confirm the role of OGT in cisplatin resistance. Autophagy-related proteins were tested by western blot. Transmission electron microscopy and mRFP-GFP-LC3 adenovirus reporter were used for autophagy flux analysis. Immunoprecipitation assay was utilized to detect protein-protein interactions. Results: We found that O-GlcNAc and O-GlcNAc transferase (OGT) levels were significantly lower in chemoresistant ovarian cancer tissues than in chemosensitive tissues, whereas O-GlcNAcase (OGA) levels did not differ. The down-regulation of OGT increased cisplatin resistance in ovarian cancer cells but had no effect on the efficacy of paclitaxel. The down-regulation of OGT improved tumor resistance to cisplatin in a mouse xenograft tumor model. OGT knockdown enhanced cisplatin-induced autophagy, which reduced apoptotic cell death induced by cisplatin, and promoted autolysosome formation. A reduction in O-GlcNAcylated SNAP-29 levels caused by the down-regulation of OGT promoted the formation of the SNARE complex and autophagic flux. Conclusion: Our findings suggest that down-regulation of OGT enhances cisplatin-induced autophagy via SNAP-29, resulting in cisplatin-resistant ovarian cancer. OGT may represent a novel target for overcoming cisplatin resistance in ovarian cancer.
30555541	19	22	OGT	Gene	8473
30555541	32	41	cisplatin	Chemical	MESH:D002945
30555541	78	92	ovarian cancer	Disease	MESH:D010051
30555541	94	103	Cisplatin	Chemical	MESH:D002945
30555541	158	166	patients	Species	9606
30555541	172	186	ovarian cancer	Disease	MESH:D010051
30555541	227	236	cisplatin	Chemical	MESH:D002945
30555541	251	265	ovarian cancer	Disease	MESH:D010051
30555541	353	356	OGT	Gene	8473
30555541	358	361	OGA	Gene	10724
30555541	366	374	O-GlcNAc	Gene	8473
30555541	412	426	ovarian cancer	Disease	MESH:D010051
30555541	517	520	OGT	Gene	8473
30555541	524	533	cisplatin	Chemical	MESH:D002945
30555541	648	651	LC3	Gene	84557
30555541	813	821	O-GlcNAc	Gene	8473
30555541	826	846	O-GlcNAc transferase	Gene	8473
30555541	848	851	OGT	Gene	8473
30555541	903	917	ovarian cancer	Disease	MESH:D010051
30555541	966	977	O-GlcNAcase	Gene	10724
30555541	979	982	OGA	Gene	10724
30555541	1030	1033	OGT	Gene	8473
30555541	1044	1053	cisplatin	Chemical	MESH:D002945
30555541	1068	1082	ovarian cancer	Disease	MESH:D010051
30555541	1126	1136	paclitaxel	Chemical	MESH:D017239
30555541	1161	1164	OGT	Gene	108155
30555541	1174	1179	tumor	Disease	MESH:D009369
30555541	1194	1203	cisplatin	Chemical	MESH:D002945
30555541	1209	1214	mouse	Species	10090
30555541	1225	1230	tumor	Disease	MESH:D009369
30555541	1238	1241	OGT	Gene	108155
30555541	1261	1270	cisplatin	Chemical	MESH:D002945
30555541	1336	1345	cisplatin	Chemical	MESH:D002945
30555541	1414	1421	SNAP-29	Gene	9342
30555541	1462	1465	OGT	Gene	8473
30555541	1496	1501	SNARE	Gene	56494
30555541	1588	1591	OGT	Gene	8473
30555541	1601	1610	cisplatin	Chemical	MESH:D002945
30555541	1633	1640	SNAP-29	Gene	9342
30555541	1655	1664	cisplatin	Chemical	MESH:D002945
30555541	1675	1689	ovarian cancer	Disease	MESH:D010051
30555541	1691	1694	OGT	Gene	8473
30555541	1739	1748	cisplatin	Chemical	MESH:D002945
30555541	1763	1777	ovarian cancer	Disease	MESH:D010051
30555541	Association	56494	9342
30555541	Association	56494	8473
30555541	Negative_Correlation	8473	9342
30555541	Negative_Correlation	MESH:D002945	8473
30555541	Association	MESH:D002945	108155
30555541	Negative_Correlation	MESH:D010051	8473
30555541	Negative_Correlation	MESH:D002945	MESH:D010051

